Potassium Chloride

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Potassium Chloride
Generic name: POTASSIUM CHLORIDE
Manufacturer: Endo USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: a64d7151-09a6-474c-83fc-36c7cf582d32
SPL ID: 05260a26-2484-4fd1-9ca1-8445f239923e
Version: 6
Effective date: 2025-03-26
Source export date: 2026-11-06
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/39f3c0903357a80632a5484c9d6a804272f4b297080aa9c5a01a84db133f7a03/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 08:00:44

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 16 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	NDA	208019	derived:openfda.application_number
application number		NDA208019	openfda.application_number
brand name		Potassium Chloride	openfda.brand_name
generic name		POTASSIUM CHLORIDE	openfda.generic_name
manufacturer name		Endo USA, Inc.	openfda.manufacturer_name
ndc	package	0603-1554-16	openfda.package_ndc
ndc	package	0603-1554-10	openfda.package_ndc
ndc	package	0603-1554-04	openfda.package_ndc
ndc	product	0603-1554	openfda.product_ndc
ndc11	package	00603155410	derived:openfda.package_ndc
ndc11	package	00603155416	derived:openfda.package_ndc
ndc11	package	00603155404	derived:openfda.package_ndc
rxcui		1867544	openfda.rxcui
spl id		05260a26-2484-4fd1-9ca1-8445f239923e	id
spl set id		a64d7151-09a6-474c-83fc-36c7cf582d32	set_id
unii		660YQ98I10	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

5 WARNINGS AND PRECAUTIONS Gastrointestinal Irritation: Dilute before use, take with meals ( 5.1 ) 5.1 Gastrointestinal Irritation May cause gastrointestinal irritation. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration (2.1) ] .

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

6 ADVERSE REACTIONS The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. Most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Allucent at 1-866-511-6754 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.